| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $1.14B | +9.6% |
| Cost of Revenue | $849.1M | +10.5% |
| Gross Profit | $287.2M | +6.9% |
| R&D Expense | $40.3M | +4.9% |
| SG&A Expense | $214.0M | +8.2% |
| Operating Income | $29.0M | -6.8% |
| Interest Expense | $15.2M | -30.0% |
| Pre-tax Income | $26.5M | +138.7% |
| Income Tax | $10.2M |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $329.3M | +352.3% |
| Accounts Receivable | $117.5M | -8.8% |
| Current Assets | $872.1M | +46.8% |
| Total Assets | $1.95B | +19.5% |
| Current Liabilities | $296.7M | +1.4% |
| Long-term Debt | $174.6M | -20.4% |
| Total Liabilities | $597.7M | -5.7% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $49.7M | -23.8% |
| Investing Cash Flow | -$69.7M | -59.1% |
| Financing Cash Flow | $277.6M | +1004.2% |
| +14.6% |
| Net Income | $16.3M | +283.1% |
| EPS (Basic) | $0.11 | +257.1% |
| EPS (Diluted) | $0.11 | +257.1% |
| Stockholders' Equity |
| $1.35B |
| +38.6% |